Sage Journals: Discover world-class research

Abstract

Although the eye itself is regarded an ‘immune-privileged’ organ, systemic lupus erythematosus (SLE) can affect every ocular structure, leading, if left untreated, to significant visual loss or even blindness. Since ocular inflammation in SLE can antedate the diagnosis of the systemic disease and cause significant morbidity, prompt diagnosis and treatment of the underlying systemic autoimmune disease is imperative.

Keywords

antimalarials keratoconjunctivitis sicca retina scleritis systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Wallace DJ. The clinical presentation of systemic lupus erythematosus. In Wallace DJ , Hahn BH eds. Dubois’ lupus erythematosus. Philadelphia, PA: Lippincott Williams & Wilkins , 1997: 627-633.

Steinberg AD , Talal N. The coexistence of Sjögren’s syndrome and systemic lupus erythematosus . Ann Intern Med 1971; 74: 55-61 .

Jensen JL , Bergem HO , Gilboe IM , Husby G , Axell T. Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus . J Oral Pathol Med 1999; 28: 317-322 .

Soo MP , Chow SK , Tan CT , Nadior N , Yeap SS , Hoh HB. The spectrum of ocular involvement in patients with systemic lupus erythematosus without ocular symptoms . Lupus 2000; 9: 511-514 .

Maffett MJ , Johns KJ , Parrish CM , Elliott JH , Glick AD , O’Day DM. Sterile corneal ulceration after cataract extraction in patients with collagen vascular disease . Cornea 1990; 9: 279-285 .

Hochberg MC , Boyd RE , Ahearn JM et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets . Medicine (Baltimore) 1985; 64: 285-295 .

Andonopoulos AP , Skopouli FN , Dimou GS , Drosos AA , Moutsopoulos HM. Sjögren’s syndrome in systemic lupus erythematosus . J Rheumatol 1990; 17: 201-204 .

Huey C , Jakobiec FA , Iwamoto T , Kennedy R , Farmer ER , Green WR. Discoid lupus erythematosus of the eyelids . Ophthalmology 1983; 90: 1389-1398 .

Burge SM , Frith PA , Juniper RP , Wojnarowska F. Mucosal involvement in systemic and chronic cutaneous lupus erythematosus . Br J Dermatol 1989; 121: 727-741 .

10.

Paroli MP , Riso D , Pinca M , Pivetti-Pezzi P. Chorioretinopathy and discoid plaque-like lesions of the eyelids as useful indicators of systemic lupus erythematosus (SLE) progression . Lupus 2001; 10: 571-575 .

11.

Mehta AM , France TD. Prominent ocular findings as an early manifestation of systemic lupus erythematosus . J Pediatr Ophthalmol Strabismus 1998; 35: 114-115 .

12.

Donzis PB , Insler MS , Buntin DM , Wolfley D. Discoid lupus erythematosus involving the eyelids . Am J Ophthalmol 1984; 98: 32-36 .

13.

Frith P , Burge SM , Millard PR , Wojnarowska F. External ocular findings in lupus erythematosus: a clinical and immunopathological study . Br J Ophthalmol 1990; 74: 163-167 .

14.

Sheehan-Dare RA , Cunliffe WJ. Severe periorbital edema in association with lupus erythematosus profundus . Clin Exp Dermatol 1988; 13: 406-407 .

15.

Sontheimer RD , Rothfield N , Gilliam N. Lupus erythematosus. In Fitzpatrick TB , Eisen AZ , Wolff K , Freedberg IM , Austen KF eds. Dermatology in general medicine. New York, NY: McGraw-Hill , 1987: 1816-1834.

16.

Gold DH , Morris DA , Henkind P. Ocular findings in systemic lupus erythematosus . Br J Ophthalmol 1972; 56: 800-804 .

17.

Heiligenhaus A , Dutt JE , Foster CS. Histology and immunopathology of systemic lupus erythematosus affecting the conjunctiva . Eye 1996; 10: 425-432 .

18.

Messmer EM , Foster CS. Vasculitic peripheral ulcerative keratitis . Surv Ophthalmol 1999; 43: 379-396 .

19.

Raizman MB , Baum J. Discoid lupus keratitis . Arch Ophthalmol 1989; 107: 545-547 .

20.

Reeves JA. Keratopathy associated with systemic lupus erythematosus . Arch Ophthalmol 1965; 74: 159-160 .

21.

Varga JH , Wolf TC. Bilateral transient keratoendotheliitis associated with systemic lupus erythematosus . Ann Ophthalmol 1993; 25: 222-223 .

22.

Adan CB , Trevisani VF , Vasconcellos M , de Freitas D , de Souza LB , Mannis M. Bilateral deep keratitis caused by systemic lupus erythematosus . Cornea 2004; 23: 207-209 .

23.

Stein R. Photorefractive keratectomy . Int Ophthalmol Clin 2000; 40: 35-56 .

24.

Burrato L , Brint S. Preparation for surgery. In Burrato L , Brint S eds. Lasik. Surgical techniques and complications. New Jersey, NJ: Slack Inc , 2000, 16-17.

25.

Cua IY , Pepose JS. Late corneal scarring after photorefractive keratectomy concurrent with development of systemic lupus erythematosus . J Refract Surg 2002; 18: 750-752 .

26.

Tuffanelli DL , Dubois EL. Cutaneous manifestations of systemic lupus erythematosus . Arch Dermatol 1964; 90: 377-386 .

27.

Uy HS , Pineda R 2nd , Shore JW , Polcharoen W , Jakobiec FA , Foster CS. Hypertrophic discoid lupus erythematosus of the conjunctiva . Am J Ophthalmol 1999; 127: 604-605 .

28.

Burge SM , Frith PA , Millard PR , Wojnarowska F. The lupus band test in oral mucosa, conjunctiva and skin . Br J Dermatol 1989; 121: 743-752 .

29.

Hakin KN , Watson PG. Systemic associations of scleritis . Int Ophthalmol Clin 1991; 31: 111-129 .

30.

Pavesio CE , Meier FM. Systemic disorders associated with episcleritis and scleritis . Curr Opin Ophthalmol 2001; 12: 471-478 .

31.

Foster CS. Immunosuppressive therapy for external ocular inflamma-tory disease . Ophthalmology 1980; 87: 140-150 .

32.

Dubois EL , Tuffanelli DL. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases . JAMA 1964; 190: 104-111 .

33.

Rodriguez A , Calonge M , Pedroza-Seres M et al. Referral patterns of uveitis in a tertiary eye care center . Arch Ophthalmol 1996; 114: 593-599 .

34.

Yao L , Foster CS. Tubulointerstitial nephritis and uveitis syndrome . Int Ophthalmol Clin 2001; 41: 217-221 .

35.

Nguyen QD , Foster CS. Systemic lupus erythematosus and the eye . Int Ophthalmol Clin 1998; 38: 33-60 .

36.

Lanham JG , Barrie T , Kohner EM , Hughes GR. SLE retinopathy: evaluation by fluorescein angiography . Ann Rheum Dis 1982; 41: 473-478 .

37.

Read RW. Clinical mini-review: systemic lupus erythematosus and the eye . Ocul Immunol Inflamm 2004; 12: 87-99 .

38.

Coppeto J , Lessell S. Retinopathy in systemic lupus erythematosus . Arch Ophthalmol 1977; 95: 794-797 .

39.

Stafford-Brady FJ , Urowitz MB , Gladman DD , Easterbrook M. Lupus retinopathy. Patterns, associations, and prognosis . Arthritis Rheum 1988; 31: 1105-1110 .

40.

Aronson AJ , Ordonez NG , Diddie KR , Ernest JT. Immune-complex deposition in the eye in systemic lupus erythematosus . Arch Intern Med 1979; 139: 1312-1313 .

41.

Giorgi D , Pace F , Giorgi A , Bonomo L , Gabrieli CB. Retinopathy in systemic lupus erythematosus: pathogenesis and approach to therapy . Hum Immunol 1999; 60: 688-696 .

42.

Klinkhoff AV , Beattie CW , Chalmers A. Retinopathy in systemic lupus erythematosus: relationship to disease activity . Arthritis Rheum 1986; 29: 1152-1156 .

43.

Au A , O’Day J. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment . Clin Experiment Ophthalmol 2004; 32: 87-100 .

44.

Jabs DA , Fine SL , Hochberg MC , Newman SA , Heiner GG , Stevens MB. Severe retinal vaso-occlusive disease in systemic lupus erythematous . Arch Ophthalmol 1986; 104: 558-563 .

45.

Karpik AG , Schwartz MM , Dickey LE , Streeten BW , Roberts JL. Ocular immune reactants in patients dying with systemic lupus erythematosus . Clin Immunol Immunopathol 1985; 35: 295-312 .

46.

Graham EM , Spalton DJ , Barnard RO , Garner A , Russell RW. Cerebral and retinal vascular changes in systemic lupus erythematosus . Ophthalmology 1985; 92: 444-448 .

47.

Vine AK , Barr CC. Proliferative lupus retinopathy . Arch Ophthalmol 1984; 102: 852-854 .

48.

Glueck HI , Kant KS , Weiss MA , Pollak VE , Miller MA , Coots M. Thrombosis in systemic lupus erythematosus: relation to the presence of lupus anticoagulants . Arch Intern Med 1985; 145: 1389-1395 .

49.

Levy-Clarke GA , Nussenblatt R. Retinal vasculitis . Int Ophthalmol Clin 2005; 45: 99-113 .

50.

Levine SR , Welch KMA. The spectrum of neurologic disease associated with antiphospholipid antibodies: lupus anticoagulants and anticardiolipin antibodies . Arch Neurol 1987; 44: 876-883 .

51.

Hall S , Buettner H , Luthra HS. Occlusive retinal vascular disease in systemic lupus erythematosus . J Rheumatol 1984; 11: 846-850 .

52.

Donders RC , Kappelle LJ , Derksen RH et al. Transient monocular blindness and antiphospholipid antibodies in systemic lupus erythematosus . Neurology 1998; 51: 535-540 .

53.

Montehermoso A , Cervera R , Font J et al. Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus . Semin Arthritis Rheum 1999; 28: 326-332 .

54.

Hsiao CH , Yang BJ. Choroidopathy in a patient with suspected systemic lupus erythematosus . Retina 1998; 18: 180-182 .

55.

el-Asrar AM , Naddaf HO , al-Momen AK , al-Balla SR. Systemic lupus erythematosus flare-up manifesting as a cilioretinal artery occlusion . Lupus 1995; 4: 158-160 .

56.

Quillen DA , Stathopoulos NA , Blankenship GW , Ferriss JA. Lupus associated frosted branch periphlebitis and exudative maculopathy . Retina 1997; 17: 449-451 .

57.

Sekimoto M , Hayasaka S , Noda S , Setogawa T. Pseudoretinitis pigmentosa in patients with systemic lupus erythematosus . Ann Ophthalmol 1993; 25: 264-266 .

58.

Nguyen QD , Uy HS , Akpek EK , Harper SL , Zacks DN , Foster CS. Choroidopathy of systemic lupus erythematosus . Lupus 2000; 9: 288-298 .

59.

Jabs DA , Hanneken AM , Schachat AP , Fine SL. Choroidopathy in systemic lupus erythematosus . Arch Ophthalmol 1988; 106: 230-234 .

60.

Lavina AM , Agarwal A , Hunyor A , Gass JD. Lupus choroidopathy and choroidal effusions . Retina 2002; 22: 643-647 .

61.

Shimura M , Tatehana Y , Yasuda K , Saito S , Sasaki T , Tamai M. Choroiditis in systemic lupus erythematosus: systemic steroid therapy and focal laser treatment . Jpn J Ophthalmol 2003; 47: 312-315 .

62.

Poole TR , Graham EM. Ocular manifestations of rheumatologic disorders . Curr Opin Ophthalmol 1999; 10: 458-463 .

63.

Wakakura M , Ishikawa S. Central serous chorioretinopathy complicating systemic corticosteroid treatment . Br J Ophthalmol 1984; 68: 329-331 .

64.

Dreyer EB , Morgan CM. Subretinal neovascularization in systemic lupus erythematosus . Can J Ophthalmol 1991; 26: 159-160 .

65.

Wisotsky BJ , Magat-Gordon CB , Puklin JE. Angle-closure glaucoma as an initial presentation of systemic lupus erythematosus . Ophthalmology 1998; 105: 1170-1172 .

66.

Khng CG , Yap EY , Au-Eong KG , Lim TH , Leong KH. Central serous retinopathy complicating systemic lupus erythematosus: a case series . Clin Experiment Ophthalmol 2000; 28: 309-313 .

67.

Arevalo JF , Lowder CY , Muci-Mendoza R. Ocular manifestations of systemic lupus erythematosus . Curr Opin Ophthalmol 2002; 13: 404-410 .

68.

Herbort CP. Posterior uveitis: new insights provided by indocyanine green angiography . Eye 1998; 12: 757-759 .

69.

Diddie KR , Aronson AJ , Ernest JT. Chorioretinopathy in a case of systemic lupus erythematosus . Trans Am Ophthalmol Soc 1977; 75: 122-131 .

70.

Matsuo T , Nakayama T , Koyama T , Matsuo N. Multifocal pigment epithelial damages with serous retinal detachment in systemic lupus erythematosus . Ophthalmologica 1987; 195: 97-102 .

71.

Yap EY , Au Eong KG , Fong KY et al. Ophthalmic manifestations in Asian patients with systemic lupus erythematosus . Singapore Med J 1998; 39: 557-559 .

72.

Borruat FX , Prado T , Strominger M , Schatz NJ , Glaser JS.

[Neuroophthalmologic complications of disseminated lupus erythematosus.]

Klin Monatsbl Augenhielkd 1994; 204: 403-406 .

73.

Hackett ER , Martinez RD , Larson PF , Paddison RM. Optic neuritis in systemic lupus erythematosus . Arch Neurol 1974; 31: 9-11 .

74.

Smith CA , Pinals RS. Optic neuritis in systemic lupus erythematosus . J Rheumatol 1982; 9: 963-966 .

75.

Jabs DA , Miller NR , Newman SA , Johnson MA , Stevens MB. Optic neuropathy in systemic lupus erythematosus . Arch Ophthalmol 1986; 104: 564-568 .

76.

Ahmadieh H , Roodpeyma S , Azarmina M , Soheilian M , Sajjadi SH. Bilateral simultaneous optic neuritis in childhood systemic lupus erythematosus. A case report . J Neuroophthalmol 1994; 14: 84-86 .

77.

Lessell S. The neuro-ophthalmology of systemic lupus erythematosus . Doc Ophthalmol 1979; 47: 13-42 .

78.

Brandt KD , Lessell S , Cohen AS. Cerebral disorders of vision in systemic lupus erythematosus . Ann Intern Med 1975; 83: 163-169 .

79.

Keane JR. Eye movement abnormalities in systemic lupus erythematosus . Arch Neurol. 1995; 52: 1145-1149 .

80.

Mavrikakis M , Anastasiou-Nana M , Kalaitzidou C , Papageorgiou C. Optic neuritis and Jaccoud’s syndrome in a patient with systemic lupus erythematosus . Scand J Rheumatol 1983; 12: 367-368 .

81.

Rubin BR , DeHopatius RJ. Acute visual loss in systemic lupus erythematosus . J Am Optom Assoc 1989; 89: 73-77 .

82.

Siatkowski RM , Scott IU , Verm AM et al. Optic neuropathy and chiasmopathy in the diagnosis of systemic lupus erythematosus . J Neuroophthalmol 2001; 21: 193-198 .

83.

Champion BL , Choy F , Schrieber L , Roche J , Rowe DB. Isolated fascicular oculomotor nerve palsy as the initial presentation of the antiphospholipid syndrome . J Clin Neurosci 2002; 9: 691-694 .

84.

Levine SR , Crofts JW , Lesser GR , Floberg J , Welch KM. Visual symptoms associated with the presence of a lupus anticoagulant . Ophthalmology 1988; 95: 686-692 .

85.

Oppenheimer S , Hoffbrand BI. Optic neuritis and myelopathy in systemic lupus erythematosus . Can J Neurol Sci 1986; 13: 129-132 .

86.

Jackson G , Miller M , Littlejohn G , Helme R , King R. Bilateral internu-clear ophthalmoplegia in systemic lupus erythematosus . J Rheumatol 1986; 13: 1161-1162 .

87.

Yigit A , Bingol A , Mutluer N , Tascilar N. The one-and-a-half syndrome in systemic lupus erythematosus . J Neuroophthalmol 1996; 16: 274-276 .

88.

Johnson RT , Richardson EP. The neurological manifestations of systemic lupus erythematosus: a clinical-pathological study of 24 cases and review of the literature . Medicine 1968; 47: 337-369 .

89.

Feinglass EJ , Arnett FC , Dorsch CA , Zizic TM , Stevens MB. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease . Medicine 1976; 55: 323-339 .

90.

Padeh S , Passwell JH. Systemic lupus erythematosus presenting as idiopathic intracranial hypertension . J Rheumatol 1996; 23: 1266-1268 .

91.

Bingisser R , Speich R , Fontana A , Gmur J , Vogel B , Landis T. Lupus erythematosus and Miller-Fisher syndrome . Arch Neurol 1994; 51: 828-830 .

92.

Giorgi D , Balacco G , Bonomo L. The association of optic neuropathy wih transverse myelitis in systemic lupus erythematosus . Rheumatology 1999; 38: 191-192 .

93.

Gibbs NA , Moroney J , Foley-Nolan D , O’Connell PG. Neuromyelitis optica (Devic’s syndrome) in systemic lupus erythematosus: a case report . Rheumatology 2002; 41: 470-477 .

94.

Serop S , Vianna RN , Claeys M , De Laey JJ. Orbital myositis secondary to systemic lupus erythematosus . Acta Ophthalmol (Copenh) 1994; 72: 520-523 .

95.

Calistri V , Mostardini C , Pantano P , Pierallini A , Colonnese C , Caramia F. Tolosa-Hunt syndrome in a patient with systemic lupus erythematosus . Eur Radiol 2002; 12: 341-344 .

96.

Arthurs BP , Khalil MK , Chagnon F , Lindley SK , Anderson DP , Burnier M Jr. Orbital infraction and melting in a patient with systemic lupus erythematosus . Ophthalmology 1999; 106: 2387-2390 .

97.

Stavrou P , Murray PI , Batta K , Gordon C. Acute ocular ischaemia and orbital inflammation associated with systemic lupus erythematosus . Br J Ophthalmol 2002; 86: 474-475 .

98.

Jordan DR , McDonald H , Olberg B , McKim D , McKendry R. Orbital panniculitis as the initial manifestation of systemic lupus erythematosus . Ophthal Plast Reconstr Surg 1993; 9: 71-75 .

99.

Whitefield L , Isenberg DA , Brazier DJ , Forbes J. Acquired Brown’s syndrome in systemic lupus erythematosus . Br J Rheumatol 1995; 34: 1092-1094 .

100.

McGalliard J , Bell AL. Acquired Brown’s syndrome in systemic lupus erythematosus: another ocular manifestation . Clin Rheumatol 1990; 9: 399-400 .

101.

Carnahan MC , Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids . Curr Opin Ophthalmol 2000; 11: 478-483 .

102.

Hanania NA , Chapman KR , Kesten S. Adverse effects of inhaled corticosteroids . Am J Med 1995; 98: 196-208 .

103.

Black RL , Oglesby RB , von Sallman L , Bunim JJ. Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis . JAMA 1960; 174: 166-171 .

104.

Urban RC Jr , Cotlier E. Corticosteroid-induced cataracts . Surv Ophthalmol 1986; 31: 102-110 .

105.

Maiorca R , Cristinelli L , Brunori G et al. Prospective controlled trial of steroid withdrawal after six months in renal transplant patients treated with cyclosporine . Transplant Proc 1988; 20(Suppl 3): S121-S125 .

106.

Tarantino A , Aroldi A , Stucchi L et al. A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation . Transplantation 1991; 52: 53-57 .

107.

Easterbrook M. Detection and prevention of maculopathy associated with antimalarial agents . Int Ophthalmol Clin 1999; 39: 49-57 .

108.

Hollander DA , Aldave AJ. Drug-induced corneal complications . Curr Opin Ophthalmol 2004; 15: 541-548 .

109.

Easterbrook M.

Is corneal deposition of antimalarial any indication of retinal toxicity?

Can J Ophthalmol 1990; 25: 249-251 .

110.

Neubauer AS , Samari-Kermani K , Schaller U , Welge-Lubetaen U , Rudolph G , Berninger T. Detecting chloroquine retinopathy: electro-oculogram versus colour vision . Br J Ophthalmol 2003; 87: 902-908 .

111.

Bernstein HN. Chloroquine ocular toxicity . Surv Ophthalmol 1967; 12: 415-447 .

112.

Shearer RV , Dubois EL. Ocular changes induced by long-term hydroxychloroquine (plaquenil) therapy . Am J Ophthalmol 1967; 64: 245-252 .

113.

Easterbrook M. Ocular effects and safety of antimalarial agents . Am J Med 1988; 85: 23-29 .

114.

Fielder A , Graham E , Jones S , Silman A , Tullo A. Royal College of Ophthalmologists guidelines: ocular toxicity and hydroxychloroquine . Eye 1998; 12: 907-909 .

115.

Mavrikakis M , Papazoglou S , Sfikakis PP , Vaiopoulos G , Rougas K. Retinal toxicity in long term hydroxychloroquine treatment . Ann Rheum Dis 1996; 55: 187-189 .

116.

Silman A , Shipley M. Ophthalmological monitoring for hydroxychloroquine toxicity: a scientific review of available data . Br J Rheumatol 1997; 36: 599-601 .

117.

Johnson MW , Vine AK. Hydroxychloroquine therapy in massive total doses without retinal toxicity . Am J Ophthalmol 1987; 104: 139-144 .

118.

Marmor MF , Carr RE , Easterbrook M , Farjo AA , Mieler WF ; American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology . Ophthalmology 2002; 109: 1377-1382 .

119.

Moschos MN , Moschos MM , Apostolopoulos M , Mallias JA , Bouros C , Theodossiadis GP. Assessing hydroxychloroquine toxicity by the multifocal ERG . Doc Ophthalmol 2004; 108: 47-53 .

120.

Fossaluzza V , Dal Mas P. Proptosis and systemic lupus erythematosus . Clin Exp Rheumatol 1987; 5: 192-193 .

121.

DelGiudice GC , Scher CA , Athreya BH , Diamond GR. Pseudotumor cerebri and childhood systemic lupus erythematosus . J Rheumatol 1986; 13: 748-752 .

122.

Graham EM , Stanford MR , Whitcup SM. Retinal vasculitis. In Pepose JS , Holland GN , Wilhelmus KR eds. Ocular infection & immunity. St. Louis, MO: Mosby , 1996: 538-552.

123.

Stanford MR , Verity DH. Diagnostic and therapeutic approach to patients with retinal vasculitis . Int Ophthalmol Clin 2000; 40: 69-83 .

124.

Walton RC , Ashmore ED. Retinal vasculitis . Curr Opin Ophthalmol 2003; 14: 413-419 .

125.

Neumann R , Foster CS. Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus . Retina 1995; 15: 201-212 .

126.

Galindo-Rodriguez G , Avina-Zubieta JA , Pizarro S et al. Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: an open trial . Am J Med 1999; 106: 65-69 .

127.

Laskin CA , Clark CA , Spitzer KA.

Antiphospholipid syndrome in systemic lupus erythematosus: is the whole greater than the sum of its parts?

Rheum Dis Clin North Am 2005; 31: 255-272 .

128.

Perry HD , Donnenfeld ED. Topical 0.05% cyclosporin in the treatment of dry eye . Expert Opin Pharmacother 2004; 5: 2099-2107 .

129.

Fox RI. Sjogren’s syndrome: evolving therapies . Expert Opin Investig Drugs 2003; 12: 247-254 .

130.

Meldrum ML , Kurban RS , Foster CS , Albert DM , O’Brien JM. Collagen vascular diseases: cutaneous manifestations in ophthalmology . Ophthal Plast Reconstr Surg 2000; 16: 459-470 .

131.

Ladas JG , Mondino BJ. Systemic disorders associated with peripheral corneal ulceration . Curr Opin Ophthalmol 2000; 11: 468-471 .

Ocular manifestations of systemic lupus erythematosus: a clinical review

Abstract

Keywords

Get full access to this article

References